Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 1/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 13/20 | 0.48 |
| ▸ | CA12 | O43570 | 12/20 | 0.48 |
| ▸ | CA1 | P00915 | 12/20 | 0.48 |
| ▸ | CA9 | Q16790 | 7/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 7/20 | 0.43 |
| ▸ | CA5A | P35218 | 7/20 | 0.43 |
| ▸ | CA7 | P43166 | 7/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5188859 | 1.00 | NR3C1 (0.55) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL19555531 | 0.99 | NR3C1 (0.53) | NR3C1FYNADRA2AADORA3ADRA2B | |
| Phosphine SCHEMBL11552462 | 0.90 | NR3C1 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL12716359 | 0.90 | CYP2D6 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL1582750 | 0.90 | CYP2D6 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL13576463 | 0.90 | CYP2D6 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL10982935 | 0.90 | CYP2D6 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL2353098 | 0.90 | CYP2D6 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL1582644 | 0.90 | CYP2D6 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B | |
| SCHEMBL9887803 | 0.90 | CYP2D6 (0.58) | NR3C1FYNADRA2AADORA3ADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 21250 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260103532-A1 | PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF | KINIKSA PHARMACEUTICALS GMBH (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260092050-A1 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | RAPT THERAPEUTICS INC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260091162-A1 | SPRAYABLE POLYMERIC SCAFFOLD LOADED WITH INFLAMMASOME-INHIBITING LIPID NANORODS FOR ANTI-INFLAMMATION THERAPY | KULKARNI ASHISH (US) | 2026-04-02 | — | — | US | claimed |
| EP-4701663-A1 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS, COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-03-04 | — | — | EP | claimed |
| EP-4058037-B1 | FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE | SPINALCYTE LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-20260014189-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT | UNIV SOONCHUNHYANG IND ACAD COOP FOUND (KR) | 2026-01-15 | — | — | US | claimed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-0055009-B1 | DOSAGE UNITS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-11-05 | — | — | EP | claimed |
| EP-0055009-A1 | Dosage units | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1982-06-30 | — | — | EP | claimed |
| WO-1982001818-A1 | DOSAGE UNITS | SMITH KLINE FRENCH LAB (GB) | 1982-06-10 | — | — | WO | claimed |
| US-4200738-A | Method for preparing auranofin | SMITHKLINE CORPORATION (US) | 1980-04-29 | — | — | US | claimed |
| US-4133952-A | Process and intermediate for preparing auranofin | SMITHKLINE CORPORATION (US) | 1979-01-09 | — | — | US | claimed |
| US-4131732-A | Method for preparing auranofin | SMITHKLINE CORPORATION (US) | 1978-12-26 | — | — | US | claimed |
| US-4125710-A | Method for preparing auranofin | SMITHKLINE CORPORATION (US) | 1978-11-14 | — | — | US | claimed |
| US-4125711-A | Process for preparing auranofin | SMITHKLINE CORPORATION (US) | 1978-11-14 | — | — | US | claimed |
| US-4122254-A | Process for preparing auranofin | SMITHKLINE CORPORATION (US) | 1978-10-24 | — | — | US | claimed |
| US-4115642-A | Method for preparing auranofin | SMITHKLINE CORPORATION (US) | 1978-09-19 | — | — | US | claimed |